ArticleTheranostics2021

A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance.

Qiyao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.